Quantum Genomics - Share From reverse s

LTS:0D1J (France)   Share From reverse split
€ 0.07 (0%) Dec 27
At Loss
Market Cap:
€ 5.02M ($ 5.24M)
Enterprise V:
€ 6.69M ($ 6.98M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset -1.99
Debt-to-Equity -1.34
Debt-to-EBITDA -0.29
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.22
Distress
Grey
Safe
Beneish M-Score 0.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -44.65
12-1 Month Momentum % -28.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.86
Quick Ratio 0.86
Cash Ratio 0.72
Days Sales Outstanding 36.2
Days Payable 96.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.4
Shareholder Yield % -342.27

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -4776.36
Operating Margin % -4972.4
Net Margin % -4121.49
FCF Margin % -3341.49
ROE % -331.74
ROA % -921.08
ROIC % -146.28
ROC (Joel Greenblatt) % -409200
ROCE % -279.45

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 4.24
EV-to-EBIT -0.82
EV-to-EBITDA -0.82
EV-to-Revenue 11.06
EV-to-FCF -0.33
Earnings Yield (Greenblatt) % -121.95
FCF Yield % -402.71

Financials

LTS:0D1J's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Quantum Genomics Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.605
EPS (TTM) (€) -0.118
Beta -0.92
Volatility % 51.8
14-Day RSI 0
14-Day ATR (€) 0.000096
20-Day SMA (€) 0.07196
12-1 Month Momentum % -28.04
52-Week Range (€) 0.07196 - 0.13231
Shares Outstanding (Mil) 69.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Quantum Genomics Filings

Filing Date Document Date Form
No Filing Data

Quantum Genomics Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Quantum Genomics Frequently Asked Questions

What is Quantum Genomics(LTS:0D1J)'s stock price today?
The current price of LTS:0D1J is €0.07. The 52 week high of LTS:0D1J is €0.13 and 52 week low is €0.07.
When is next earnings date of Quantum Genomics(LTS:0D1J)?
The next earnings date of Quantum Genomics(LTS:0D1J) is .
Does Quantum Genomics(LTS:0D1J) pay dividends? If so, how much?
Quantum Genomics(LTS:0D1J) does not pay dividend.

Press Release

Subject Date
No Press Release